Sector revisions Genmab A/S Nasdaq

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-22 pm EDT			5-day change	1st Jan Change
28.85 ^USD	+1.71%		-0.79%	-6.33%

12:50am	Nordic stocks in North America, Ericsson fell 1.2%	FW
Jul. 22	TD Cowen Upgrades Genmab to Buy Rating, Boosts PT	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	INSMED INCORPORATED							22
	BIONTECH SE							20
	WUXI BIOLOGICS (CAYMAN) INC.							23
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							17
	PHARMAESSENTIA CORPORATION							7
	EXELIXIS, INC.							15
	MADRIGAL PHARMACEUTICALS, INC.							14
	SUMMIT THERAPEUTICS INC.							13
	AKESO, INC.							20
	CYTOKINETICS, INCORPORATED							20
	ARROWHEAD PHARMACEUTICALS, INC.							11
	REMEGEN CO., LTD.							15
	CRINETICS PHARMACEUTICALS, INC.							10
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							-
	IMMUNITYBIO, INC.							3
	VAXCYTE, INC.							9
	Average							15
	Weighted average by Cap.							16